HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

peritoneal dialysate-depressor-I

potent hypotensive lipid from dog peritoneal dialysate; estimated to be a choline-containing phospholipid

Also Known As:

PDD-I

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Lipids: 114793
- Membrane Lipids: 1591
  - Phospholipids: 11903
    - peritoneal dialysate-depressor-I: 2

Experts

1.	A Armstrong, Richard: 1 article (01/2017)
2.	Rodi, Melissa L: 1 article (04/2014)
3.	Young, Robyn L: 1 article (04/2014)

Related Diseases

1.	Asperger Syndrome (Asperger's Syndrome) 04/01/2014 - "Of the 210 participants in the present study who met DSM-IV-TR criteria for a PDD [i.e., autistic disorder, Asperger's disorder and pervasive developmental disorder-not otherwise specified (PDD-NOS)], only 57.1% met DSM-5 criteria (specificity = 1.0) for autism spectrum disorder when criteria were applied concurrently during diagnostic assessment. "
2.	Autistic Disorder (Autism) 04/01/2014 - "Of the 210 participants in the present study who met DSM-IV-TR criteria for a PDD [i.e., autistic disorder, Asperger's disorder and pervasive developmental disorder-not otherwise specified (PDD-NOS)], only 57.1% met DSM-5 criteria (specificity = 1.0) for autism spectrum disorder when criteria were applied concurrently during diagnostic assessment. "
3.	Autism Spectrum Disorder 04/01/2014 - "Of the 210 participants in the present study who met DSM-IV-TR criteria for a PDD [i.e., autistic disorder, Asperger's disorder and pervasive developmental disorder-not otherwise specified (PDD-NOS)], only 57.1% met DSM-5 criteria (specificity = 1.0) for autism spectrum disorder when criteria were applied concurrently during diagnostic assessment. "
4.	Dementia (Dementias) 01/01/1987 - "A double-blind, placebo-controlled randomized design was employed to test the efficacy and optimal dosage of Suloctidil in the treatment of primary degenerative dementia (PDD i.e., Alzheimer's disease). "
5.	Alzheimer Disease (Alzheimer's Disease) 01/01/1987 - "A double-blind, placebo-controlled randomized design was employed to test the efficacy and optimal dosage of Suloctidil in the treatment of primary degenerative dementia (PDD i.e., Alzheimer's disease). "

Related Drugs and Biologics

1.	Suloctidil